Counselors in Emory, TX Accepting Medicare
5 Counselors found. Showing 1 - 5
 Ms. Kimberley C. Premo, M.S., LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 499 Rs County Road 3446, Emory, TX 75440 Phone: 214-536-1334 |
Tina Marie Dominy, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 446 Rains County Road 4261, Emory, TX 75440 Phone: 281-658-9986 |
 Mr. Joey Glenn Garner, LPC Counselor - Professional Medicare: Medicare Enrolled Practice Location: 1599 Rains County Rd. 1315, Emory, TX 75440 Phone: 903-473-1313 |
Kathy Lynn Mclelland, M.S., LPC Counselor - Professional Medicare: Medicare Enrolled Practice Location: 189 North Texas Street, Emory, TX 75440 Phone: 903-539-5956 |
Joyce Hogue Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 129 Rs County Road 2182, Emory, TX 75440 Phone: 903-408-7448 |
News Archive
Social media use linked to poor mental health in Indonesia
Social media use is contributing to poor mental health in Indonesia, research by Sujarwoto Sujarwoto, Gindo Tampubolon and Adi Cilik Pierewanhas found.
Diacetylmorphine more cost-effective than MMT in treating street heroin users
Medically prescribed heroin is more cost-effective than methadone for treating long-term street heroin users, according to a new study by researchers at Providence Health Care and the University of British Columbia.
Clinical studies participated by three investigators to be presented at ASH Annual Meeting and Exposition
US Oncology, Inc., the nation's leading integrated oncology company, announced today that three investigators affiliated with US Oncology Research participated in studies that will be presented orally at the 52nd American Society of Hematology Annual Meeting and Exposition at the Orange County Convention Center in Orlando, Fla. Dec. 4-7. Five other investigators in the US Oncology Research Network participated in a study that will be displayed as a poster during the conference.
Study sheds light on working principles of various advanced biosensing technologies
The COVID-19 pandemic is undoubtedly the most challenging global health burden since the 2nd World War. The pandemic has raised social awareness on the importance of effective and timely diagnosis that may help minimize the risk of contracting and spreading COVID-19.
New data on EHT 0202 for treatment of patients with AD presented at Geneva/Springfield Symposium
ExonHit Therapeutics announced today that promising new data on EHT 0202, its lead candidate in Alzheimer's disease, were presented at the 11th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy from March 24th to March 27th in Geneva, Switzerland.
› Verified 5 days ago